A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT04408638 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04408638
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-23
- Primary completion
- 2028-03-31
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.